Etodolac Tablet, Film Coated, Extended Release
Product Images NDC 60760-298

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 60760-298). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Etodolac 60760 298 15

Label for Etodolac Extended-Release Tablets, USP 500 mg, quantity 15. The label includes product and packaging details such as NDC 60760-298-15, lot number, expiration date placeholders, and manufacturing by Cadila Healthcare Ltd., Ahmedabad, India. Packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. Instructions include "USE AS DIRECTED" and storage at controlled room temperature 15°-30°C (59°-86°F).*

FDA Label Image

Etodolac Extended-release Tablets, Usp (E628f96d 7191 4338 8d08 D79345348da4 01)

Chemical structure of Etodolac, showing its bicyclic core with an indole and a tetrahydrofuran ring, including the ethyl groups and carboxylic acid moiety visible in the molecular diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.